newsfilter
← Latest News
Business Wire·

Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference

Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the Canaccord Genuity